Ophirex is developing an oral treatment that targets the most lethal components of snake venom, enabling immediate administration in rural areas where access to medical care is limited. This affordable solution aims to reduce the high mortality and morbidity rates associated with snakebites, which affect over 500,000 individuals annually.
Funding
$44.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Snakebites affect millions globally, particularly in rural areas with limited access to medical facilities. The time delay between a bite and antivenom treatment often leads to severe health consequences, including death or permanent disability. Existing antivenoms are expensive and require administration in a clinical setting, making them inaccessible to many victims.
Solution
Ophirex is developing an affordable, orally administered treatment designed to neutralize the most lethal components found in the majority of venomous snakes worldwide. This "time of bite" medication aims to halt the progression of venom-induced damage immediately after a snakebite, even in remote locations. By targeting a common venom component, the treatment offers a broad-spectrum solution that can be deployed rapidly, reducing mortality and long-term morbidity associated with snake envenomation. The oral formulation allows for easier administration in non-clinical settings, potentially saving lives and preventing debilitating injuries.
Target Audience
The primary target audience includes individuals living in rural areas with high snakebite incidence, healthcare providers in developing countries, and global health organizations focused on reducing the burden of snake envenomation.
Features
- Oral formulation for rapid administration at the site of the bite
- Broad-spectrum efficacy against a wide range of snake venoms
- Targets the most lethal components present in 95% of venomous snakes
- Designed for use in rural and resource-limited settings
- Cost-effective manufacturing to ensure affordability and accessibility